Study of a Drug [DCVax (tm)-Prostate] to Treat Prostate Cancer When Hormone Therapy is no Longer Effective.
Public ClinicalTrials.gov record NCT00043212. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled Phase III Clinical Trial Evaluating DCVax(tm)-Prostate, Autologous Dendritic Cells Loaded With Recombinant PSMA for the Treatment of Metastatic Hormone Refractory Prostate Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this clinical research study is to assess the safety and efficacy of an investigational therapy called DCVax(TM)-Prostate.
Study identification
- NCT ID
- NCT00043212
- Recruitment status
- Withdrawn
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Apr 30, 2013
United States locations
- U.S. sites
- 16
- U.S. states
- 14
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Highlands Oncology Group | Springdale | Arkansas | — | — |
| University of California, Los Angeles | Los Angeles | California | — | — |
| University of California, San Diego Medical Center | San Diego | California | — | — |
| Walter Reed Army Medical Center | Washington D.C. | District of Columbia | — | — |
| Cancer Centers of Florida, P.A. | Orlando | Florida | — | — |
| St. Francis Medical Center | Peoria | Illinois | — | — |
| Louisiana State University | New Orleans | Louisiana | — | — |
| Clinical Research Solutions | Las Vegas | Nevada | — | — |
| Albany Regional Cancer Center | Albany | New York | — | — |
| Carolinas HealthCare System | Charlotte | North Carolina | — | — |
| Cleveland Clinic Foundation | Cleveland | Ohio | — | — |
| Mary Crowley Medical Research Center | Dallas | Texas | — | — |
| Tyler Cancer Center | Tyler | Texas | — | — |
| University of Utah | Salt Lake City | Utah | — | — |
| Cancer Care Northwest | Spokane | Washington | — | — |
| St. Luke's Medical Center | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00043212, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 30, 2013 · Synced Sep 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00043212 live on ClinicalTrials.gov.